BRIDGEWAY CAPITAL MANAGEMENT, LLC - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 51 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$12,545
-82.3%
96,500
-50.9%
0.00%
-100.0%
Q2 2023$70,740
-72.8%
196,500
-64.5%
0.00%
-71.4%
Q1 2023$260,094
-20.4%
553,391
-15.3%
0.01%
-12.5%
Q4 2022$326,696
-31.8%
653,391
-13.3%
0.01%
-38.5%
Q3 2022$479,000
-19.5%
753,3910.0%0.01%
-7.1%
Q2 2022$595,000
-1.8%
753,3910.0%0.01%
+16.7%
Q1 2022$606,000
-20.4%
753,3910.0%0.01%
-14.3%
Q4 2021$761,000
-25.2%
753,391
-3.8%
0.01%
-26.3%
Q3 2021$1,018,000
+67.7%
783,3910.0%0.02%
+72.7%
Q2 2021$607,000
-14.7%
783,391
+15.5%
0.01%
-15.4%
Q1 2021$712,000
-51.2%
678,391
-36.7%
0.01%
-58.1%
Q4 2020$1,458,000
+125.0%
1,072,100
+26.8%
0.03%
+106.7%
Q3 2020$648,000
+17.2%
845,600
+18.3%
0.02%
+36.4%
Q2 2020$553,000
+171.1%
715,000
+110.3%
0.01%
+120.0%
Q1 2020$204,000
-73.6%
340,0000.0%0.01%
-50.0%
Q4 2019$772,000
+260.7%
340,0000.0%0.01%
+233.3%
Q3 2019$214,000
-26.5%
340,0000.0%0.00%
-25.0%
Q2 2019$291,000
-21.6%
340,0000.0%0.00%
-20.0%
Q1 2019$371,000
+155.9%
340,000
+79.9%
0.01%
+150.0%
Q1 2018$145,000
-33.8%
189,0000.0%0.00%0.0%
Q4 2017$219,000
+160.7%
189,000
+195.3%
0.00%
+100.0%
Q3 2017$84,000
-60.2%
64,000
-48.8%
0.00%
-66.7%
Q2 2017$211,000125,0000.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
COURAGE CAPITAL MANAGEMENT LLC 1,000,000$804,0000.77%
Sargent Investment Group, LLC 3,643,979$2,931,0000.74%
Arkadios Wealth Advisors 1,399,000$1,125,0000.15%
Kingsbury Capital Investment Advisors LLC 119,949$96,0000.11%
JTC Employer Solutions Trustee Ltd 775,000$632,0000.07%
Platform Technology Partners 142,410$115,0000.06%
Main Street Financial Solutions, LLC 400,826$322,0000.05%
National Wealth Management Group, LLC 32,100$25,8210.02%
STALEY CAPITAL ADVISERS INC 600,000$483,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 753,391$606,0000.01%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders